Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

349
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
349
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

143
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
143
Genetic Screens02:46

Genetic Screens

4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
Karyotyping01:17

Karyotyping

49.4K
Overview
49.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing short- and medium-term fluctuations of EEG spectral content in Minimally Conscious State patients.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Impact of latency jitter correction on offline P300-based classification: a preliminary study for BCI applications in MCS patients.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

The role of intralaminar damages on the delamination evolution in laminated composite structures.

Heliyon·2023
Same author

Additive manufactured polymeric shock absorbers for automotive applications.

Heliyon·2022
Same author

Qualitative mucin disorders in patients with primary Sjögren's syndrome: a literature review.

Medicina oral, patologia oral y cirugia bucal·2020
Same author

Adjusting climate model bias for agricultural impact assessment: How to cut the mustard.

Climate services·2020
Same journal

The Role of the Nurse in the Management of Irritable Bowel Syndrome: A Narrative Review.

Translational medicine @ UniSa·2025
Same journal

The Time for a Consensus Regarding the Coeliac Disease Diagnosis in Adults has come: Balancing the Pros and Cons of Omitting the Biopsy.

Translational medicine @ UniSa·2025
Same journal

Artificial Intelligence in Interventional Pain Management: Opportunities, Challenges, and Future Directions.

Translational medicine @ UniSa·2025
Same journal

Cross-sectional Study on Medical Attitude Towards Artificial Intelligence Use in Fibromyalgia: Insights From the Annual Thinking Lab on Fibromyalgia Syndrome (ATLAS 2024).

Translational medicine @ UniSa·2025
Same journal

The Association of C-Mill With Traditional Physical Therapy Rehabilitation in a Multiple Sclerosis Patient: A Case Report.

Translational medicine @ UniSa·2025
Same journal

Deep Sedation in High-risk Patients Undergoing Emergency Upper GI Endoscopy: A Retrospective Study Assessing Safety and Effectiveness.

Translational medicine @ UniSa·2025
See all related articles

Related Experiment Video

Updated: May 5, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K

Genetic Test for the Channelopaties: Useful or Less Than Useful for Patients? (Part II).

R Romano1, V Parisi, F Pastore

  • 1Department of Surgery and Cancer, Imperial College London.

Translational Medicine @ Unisa
|November 20, 2013
PubMed
Summary
This summary is machine-generated.

Genetic testing for cardiomyopathies offers precise diagnoses but remains controversial. Integrating genetic analysis into a structured diagnostic pathway is crucial for evaluating patient risks, benefits, and costs.

Keywords:
Brugada SyndromeCatecholaminergic Polymorphic Ventricular TachycardiaChannelopatiesGenetic TestingLong QT SyndromeShort QT Syndrome

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

22.2K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K

Related Experiment Videos

Last Updated: May 5, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

22.2K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Genetic testing for cardiomyopathies is increasingly available, aiding precise diagnosis.
  • The clinical utility and integration of genetic testing into diagnostic pathways are debated.
  • Channelopathies, though less common, are significant cardiac conditions with potential for sudden fatal events in asymptomatic individuals.

Purpose of the Study:

  • To clarify the clinical role of genetic testing in channelopathies.
  • To emphasize the importance of a structured diagnostic approach for genetic testing in cardiomyopathies.
  • To highlight the need for risk-benefit and cost-effectiveness analysis in genetic testing.

Main Methods:

  • Literature review on genetic testing in cardiomyopathies and channelopathies.
  • Analysis of current diagnostic guidelines and clinical utility studies.
  • Discussion of ethical and economic considerations for genetic testing.

Main Results:

  • Genetic testing provides definitive diagnostic information for various cardiomyopathies.
  • Channelopathies represent a critical area where genetic insights can prevent sudden cardiac death.
  • A comprehensive diagnostic framework is necessary to optimize the use of genetic testing.

Conclusions:

  • Genetic testing is a valuable tool in diagnosing cardiomyopathies, including channelopathies.
  • Integrating genetic testing requires careful consideration of patient-specific factors and healthcare economics.
  • Further research and standardized guidelines are needed to enhance the clinical application of genetic testing.